Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F, AURORA Study Group. N Engl J Med. 2009 Apr 2;360(14):1395-407
Related Articles:
- Effect of Angiotensin Receptor Blockers on Cardiovascular Events in Patients Undergoing Hemodialysis: An Open-Label Randomized Controlled Trial.
- Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
- Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients.
Recent Comments